The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 05, 2018
Filed:
Nov. 08, 2013
Applicant:
Lg Chem, Ltd., Seoul, KR;
Inventors:
Sung Bae Lee, Daejeon, KR;
Seung Yup Paek, Daejeon, KR;
Sook Kyung Yoon, Daejeon, KR;
Seung Hyun Yoon, Daejeon, KR;
Jeung Soon Choi, Daejeon, KR;
Assignee:
LG CHEM, LTD., Seoul, KR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 209/08 (2006.01); C07D 209/18 (2006.01); C07D 209/14 (2006.01); C07D 209/12 (2006.01); C07D 209/00 (2006.01); C07D 231/56 (2006.01); C07D 231/54 (2006.01); C07D 249/18 (2006.01); C07D 471/04 (2006.01); A61K 31/405 (2006.01); A61K 31/404 (2006.01); A61K 31/407 (2006.01); A61K 31/416 (2006.01); A61K 31/4162 (2006.01); A61K 31/4192 (2006.01); C07D 409/04 (2006.01); C07D 413/14 (2006.01); C07D 401/06 (2006.01); C07D 235/26 (2006.01); C07D 403/06 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01); C07D 417/06 (2006.01); C07D 261/20 (2006.01); C07D 209/30 (2006.01); C07D 401/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 209/08 (2013.01); C07D 209/12 (2013.01); C07D 209/30 (2013.01); C07D 231/56 (2013.01); C07D 235/26 (2013.01); C07D 249/18 (2013.01); C07D 261/20 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 409/04 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/06 (2013.01);
Abstract
The present invention relates to a novel compound having GPR40 receptor agonist activity that promotes insulin secretion and inhibits blood sugar rise after glucose loading, and is thereby useful for the treatment of diabetes and complications thereof, the preparation method thereof and pharmaceutical composition containing them as an active ingredient.